Researching: Novo Nordisk
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "Novo Nordisk"...
RxInsider Coverage (10)
The Week
The Oral GLP-1 Tracker: Lilly's Foundayo launch remains 'muted'
Jul 11
The Week
Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings
Jul 10
The Week
Rising Stars: How Novo Nordisk's Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer
Jul 1
The Week
Recent pharma exec shake-ups signal strategic shifts
Jun 24
The Week
Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
Jun 21
The Week
The Oral GLP-1 Tracker: Novo's oral Wegovy hits 3M prescription milestone as Lilly's Foundayo chugs along in early launch
Jun 9
Pipeline
CHMP Diverges from FDA, Backs AZ’s Camizestrant and Novo’s Oral Wegovy
May 23
Policy
Supreme Court shuts door on pharma's Inflation Reduction Act appeals
May 19
Pipeline
Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
May 14
Deals
Novo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech
May 14
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.